Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of a CYP17 promoter polymorphism for familial prostate cancer risk in Germany.

Anticancer research - 1 Jan 2000

Vesovic Zorica, Herkommer Kathleen, Vogel Walther, Paiss Thomas, Maier Christiane

Abstract excerpt

BACKGROUND: A thymidine to cytosine transition (designated A2 variant) in the promoter region of CYP17 has previously been associated with a familial history of prostate cancer in North American families. The purpose of the present study was to determine whether this correlation could be replicated in a European population. MATERIALS AND METHODS: Case-control comparisons were performed by modelling a dominant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Germany
Share to Odds Ratio

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Prostatic Neoplasms

Share to Risk Factors

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 15865082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of a CYP17 promoter polymorphism for familial prostate cancer risk in Germany.PMID 15865082Read ↗

Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population.Semantic proximity Read ↗

A2 allele polymorphism of the CYP17 gene and prostate cancer risk in an iranian population.Semantic proximity Read ↗

A polymorphism in the CYP17 gene and risk of prostate cancer.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

A polymorphism in the CYP17 gene is associated with prostate cancer risk.Semantic proximity Read ↗

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.Semantic proximity Read ↗

Prostate cancer associated with CYP17 genotype.Semantic proximity Read ↗

CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.Semantic proximity Read ↗

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.Semantic proximity Read ↗

Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.